Skip to main content
Clinical Trials/ACTRN12617001182381
ACTRN12617001182381
Completed
Phase 4

Treatment of alcohol dependent patients at-risk for subclinical Wernicke-Korsakoff syndrome: effect of thiamine dosage on neurological and cognitive symptoms

Prof Stephen Bowden0 sites128 target enrollmentAugust 11, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof Stephen Bowden
Enrollment
128
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2017
End Date
August 23, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof Stephen Bowden

Eligibility Criteria

Inclusion Criteria

  • Alcohol dependent patients presenting to Depaul House residential withdrawal unit.
  • Meet DSM\-IV criteria for Alcohol dependence or alcohol abuse, as assessed with the Mini International Neuropsychiatric Interview (MINI) version 6\.0\.0 (Sheehan \& Lecrubier, 2009\).
  • Consumption of at least six standard drinks daily for a period of at least three months.

Exclusion Criteria

  • Difficulties with language comprehension.
  • Significant pre\-existing cognitive impairment due to a cause other than alcohol abuse or dependence.
  • Recent regular use of any non\-prescription drug other than alcohol.

Outcomes

Primary Outcomes

Not specified

Similar Trials